The Use of Prophylactic Antibiotics in Obstetrics and Gynecology. A Review
| Autor: | P S Cartwright, S S Entman, D E Pittaway, H W Jones rd |
|---|---|
| Rok vydání: | 1984 |
| Předmět: |
medicine.medical_specialty
Time Factors Cost effectiveness Cost-Benefit Analysis Premedication medicine.medical_treatment Guinea Pigs Endometriosis Hysterectomy Dilation and curettage Obstetric Labor Premature Obstetrics and gynaecology Pregnancy Hysterectomy Vaginal medicine Animals Humans Cervical cerclage Antibiotic prophylaxis Cesarean Section business.industry Vaginal delivery Obstetrics and Gynecology Bacterial Infections Endocarditis Bacterial General Medicine medicine.disease Anti-Bacterial Agents Surgery Abortion Legal Female business Genital Diseases Female Infertility Female |
| Zdroj: | Obstetrical & Gynecological Survey. 39:537-554 |
| ISSN: | 0029-7828 |
| DOI: | 10.1097/00006254-198409000-00001 |
| Popis: | This review first makes some general comments about prophylactic antibiotics: animal models for antimicrobial prophylaxis, bacterial flora of the female genital tract, timing and duration of prophylactic antibiotic administration, and drug of choice for prophylaxis. Subsequent sections cover the following: prophylaxis for bacterial endocarditis; prophylaxis for vaginal hysterectomy; prophylaxis for elective abortions; prophylaxis for infertility and reconstructive surgery; prophylaxis for cesarean section (risk factor for postoperative infection, antibiotic of choice, timing of administration, duration of administration, and alternatives ot systemic prophylactic antibiotics); prophylactic antibiotics and cervical cerclage; and prophylaxis for preterm rupture of membranes. The recommendations are preceded by a description of the various categories suggested by the Centers for Disease Control, which recognizes that some recommendations are more firmly based on objective data than others: category 1 -- strongly recommended for adoption; category 2, moderately recommended for adoption; and category 3, weakly recommended for adoption. The recommendations include the following: all patients with a prosthetic cardiac valve should receive antibiotic prophylaxis for endometrial biopsy, insertion of IUD, urethral catheterization, dilation and curettage, hysterectomy, normal vaginal delivery, cesarean section, and sigmoidoscopy (category 1); premenopausal patients undergoing vaginal hysterectomy , with or without vaginal repair, should receive prophylactic antibiotics (category 1); and postmenopausal patients, with or without estrogen replacement therapy, may receive prophylaxis (category 2); regarding abdominal hysterectomy, patients with valvular heart disease, low socioeconomic status, cervical conization preceding hysterectomy from 2-21 days, or underlying conditions making a prolonged or difficult operation likely may benefit from prophylaxis (category 2); for elective abortion, patients with valvular heart disease, or a history of acute salpingitis may benefit from prophylaxis (category 2); patients undergoing surgical management of infertility secondary to endometriosis, pelvic adhesions, or distorted tubal architecture may benefit from prophylaxis; and regarding cesarean section, indigent or medically compromised patients with rupture of membranes over 8 hours and labor only 12 hours should receive prophylaxis (category 1). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|